APA (7th ed.) Citation

Leber, A., Hontecillas, R., Tubau‐Juni, N., & Bassaganya‐Riera, J. Safety, Tolerability, and Pharmacokinetics of NIM‐1324 an Oral LANCL2 Agonist in a Randomized, Double‐Blind, Placebo‐Controlled Phase I Clinical Trial. Wiley.

Chicago Style (17th ed.) Citation

Leber, Andrew, Raquel Hontecillas, Nuria Tubau‐Juni, and Josep Bassaganya‐Riera. Safety, Tolerability, and Pharmacokinetics of NIM‐1324 an Oral LANCL2 Agonist in a Randomized, Double‐Blind, Placebo‐Controlled Phase I Clinical Trial. Wiley.

MLA (9th ed.) Citation

Leber, Andrew, et al. Safety, Tolerability, and Pharmacokinetics of NIM‐1324 an Oral LANCL2 Agonist in a Randomized, Double‐Blind, Placebo‐Controlled Phase I Clinical Trial. Wiley.